RxDoctor Payments DataLook up a doctor →

Misty Wheelock

Adult Health · Saint Louis, MONPI 1073700217

Payments from drug & device makers

$9,217in general payments, 2019–2025

Across 516 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$846
  • Abbott$535
  • Amgen$396
  • Biohaven Pharmaceutical Holding Company Ltd.$287
  • Novartis$267
  • plus $4K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)148$3,338
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC62$846
Abbott40$535
Amgen19$396
Biohaven Pharmaceutical Holding Company Ltd.34$287
Novartis12$267
Biohaven Pharmaceuticals, Inc.25$266
Lilly USA, LLC15$256
Pfizer23$254
Collegium Pharmaceutical, Inc.16$247
Takeda Pharmaceuticals U.S.A., Inc.7$177
Johnson & Johnson8$167
Regeneron Healthcare Solutions, Inc.6$166
Genentech USA, Inc.6$155
GSK5$117
Merck5$112
AstraZeneca5$99
Eisai Inc.4$91
Incyte Corporation4$72
Sanofi4$71
Valinor Pharma, LLC4$70
Scilex Pharmaceuticals Inc.4$66
Supernus Pharmaceuticals, Inc.3$61
Recordati_rare_diseases_inc.2$60
Biodelivery Sciences International, Inc.4$57
Endo Pharmaceuticals Inc.4$55
Tersera Therapeutics LLC2$55
Exelixis Inc.2$52
Taiho Oncology, Inc.3$52
Impel Pharmaceuticals Inc.3$51
Jazz Pharmaceuticals Inc.2$47
Sobi, Inc2$46
Bayer2$44
Caris MPI, Inc.2$43
Azurity Pharmaceuticals, Inc.2$41
Servier Pharmaceuticals LLC2$41
Virtus Pharmaceuticals LLC2$33
Teva Pharmaceuticals USA, Inc.2$32
Intera Oncology, Inc1$31
Daiichi Sankyo Inc.1$28
Arbor Pharmaceuticals, Inc.2$27
Amneal Pharmaceuticals LLC2$25
Menarini Silicon Biosystems, Inc.1$24
Boehringer Ingelheim1$23
Pharmaessentia USA Corporation1$23
Lundbeck LLC1$22
Beigene USA, Inc.1$22
Ipsen Biopharmaceuticals, Inc1$19
Geron Corporation1$19
Puma Biotechnology, Inc.1$18
Genentech, Inc.1$18
Genmab U.S., Inc.1$18
Averitas Pharma Inc.1$17
Gilead1$16
Protega Pharmaceutials Inc1$15
Sumitomo Pharma America, Inc.1$14
Coherus Oncology, Inc.1$13

How this compares

$9,217 in reported general payments places this provider in the 95th percentile of 555 adult health providers in Missouri.

See all adult health providers in Missouri →

Medicare billing

Part B allowed, 2024
$4,214
Medicare patients
37
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →